IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 77 filers reported holding IGM BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,113 | +12.8% | 133,276 | +24.7% | 0.10% | -4.0% |
| Q2 2023 | $987 | +52.3% | 106,918 | +126.6% | 0.10% | +54.7% |
| Q1 2023 | $648 | +27.6% | 47,185 | +58.0% | 0.06% | +1.6% |
| Q4 2022 | $508 | -99.9% | 29,861 | +64.3% | 0.06% | +14.5% |
| Q3 2022 | $413,000 | +4.6% | 18,179 | -17.1% | 0.06% | -6.8% |
| Q2 2022 | $395,000 | -59.5% | 21,917 | -40.0% | 0.06% | -55.0% |
| Q1 2022 | $976,000 | +333.8% | 36,517 | +376.1% | 0.13% | +367.9% |
| Q4 2021 | $225,000 | -36.6% | 7,670 | +41.9% | 0.03% | -22.2% |
| Q3 2021 | $355,000 | -12.8% | 5,405 | +10.4% | 0.04% | -21.7% |
| Q2 2021 | $407,000 | +38.4% | 4,896 | +27.8% | 0.05% | -6.1% |
| Q1 2021 | $294,000 | -49.1% | 3,832 | -41.5% | 0.05% | -48.4% |
| Q4 2020 | $578,000 | – | 6,551 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |